IMMAD is a Massachusetts-based technology company that develops devices to detect impairment from THC, the psychoactive component in cannabis. Its filings show it lobbies Congress on issues related to THC impairment detection technologies and likely related testing or regulation of cannabis impairment. The company has filed five reports but reported no lobbying spending.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
This client has not yet disclosed issue activity in the available filings.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
No lobbyists are disclosed for this client yet.
The latest disclosures for this client.
COAST TO COAST LOBBYING LLC
Q1YCOAST TO COAST LOBBYING LLC
4AYCOAST TO COAST LOBBYING LLC
The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
This client's filings do not yet disclose named government entities.
COAST TO COAST LOBBYING LLC
Q3YCOAST TO COAST LOBBYING LLC
Q2YCOAST TO COAST LOBBYING LLC
Q1Y